Soo-Youn Lee June Soo Kim Jong-Won Kim
10.3349/ymj.2005.46.6.843
Yonsei Med J
2005 Dec 31;46(6):843-6.
CC BY-NC
https://pubmed.ncbi.nlm.nih.gov/16385662/
Anticoagulants / adverse effects Aryl Hydrocarbon Hydroxylases / genetics Warfarin / adverse effects
Anticoagulants / adverse effects Aryl Hydrocarbon Hydroxylases / genetics Warfarin / adverse effects Case Reports Research Support, Non-U.S. Gov't Adult Anticoagulants / administration & dosage Anticoagulants / metabolism Aryl Hydrocarbon Hydroxylases / metabolism Cytochrome P-450 CYP2C9 DNA Mutational Analysis Dose-Response Relationship, Drug Female Humans Polymorphism, Genetic Prothrombin Time Warfarin / administration & dosage Warfarin / metabolism Anticoagulants Warfarin CYP2C9 protein, human Cytochrome P-450 CYP2C9 Aryl Hydrocarbon Hydroxylases
PMC2810600
16385662
A case of intolerance to warfarin dosing in an intermediate metabolizer of CYP2C9
2005